CYCN
Cyclerion Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.52
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 28.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 21.64x
- Price / sales
- 57.95x
- Price / cash flow
- -24.74x
Enterprise value
- Enterprise value
- $108.7M
- EV / sales
- 57.22x
- EV / EBITDA
- -16.21x
- EV / EBIT
- -15.93x
- Market cap
- $110.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026